Development of Radiomics Models to Predict Progression-Free Survival and Early Polymetastatic Progression in Patients With Lung Oligometastases Treated on the Single-Arm Phase II Stereotactic Ablative Radiotherapy-5 Trial [0.03%]
基于单臂二期立体定向消融放疗-5试验的肺癌寡转移患者无进展生存期和早期多发转移进展预测模型的研发
T Kunkyab,D Hyde,B Mou et al.
T Kunkyab et al.
Aims: Despite the increasing use of stereotactic ablative radiotherapy (SABR) for oligometastatic cancer, at present, accurate models to predict the time until disease progression are lacking. The study developed radiomic...
Differential Efficacy of Immunotherapy for Hepatocellular Carcinoma by Aetiology: A Systematic Review and Meta-Analysis [0.03%]
基于病因的免疫治疗肝细胞癌疗效差异的系统评价和meta分析
Y Li,X Tan,S Fang et al.
Y Li et al.
Aims: The tumour immune microenvironment (TIME) of hepatocellular carcinoma (HCC) is distinctive across different aetiologies, potentially leading divergent responses to immune checkpoint inhibitors (ICIs). This study com...
C Maji,H Srinivasan,A Biradar et al.
C Maji et al.
P Jenkins,D Velazquez-Pimentel,J Pancholi et al.
P Jenkins et al.
Unravelling Salvage Re-irradiation for Locally Recurrent Prostate Cancer: Challenges and Complexities [0.03%]
挽救性 salvage再放疗治疗前列腺癌局部复发病灶的挑战与复杂性分析
L V Biolatti,N Ismail,A Devi et al.
L V Biolatti et al.
The management of locally radiorecurrent prostate cancer after radical treatment with external beam radiotherapy (EBRT) presents challenges due to limited comparative data on salvage modalities and concerns regarding genitourinary and gastr...
R Kanani,K Walker,L Han et al.
R Kanani et al.
The National Audit of Metastatic Breast Cancer (NAoMe): Sharing Key Findings and Recommendations From the 2025 State of the Nation Report [0.03%]
国家转移性乳腺癌审计（NAoMe）：分享2025年国家状况报告的关键发现和建议
G Hanbury,D Withrow,J Boyle et al.
G Hanbury et al.
Long-term Clinical Outcomes of a Resource-conserving Accelerated Magnetic Resonance Imaging-guided Brachytherapy Schedule for Cervix Cancer [0.03%]
一种宫颈癌磁共振图像引导的后装放疗的低成本加速方案的长期临床结果分析
L-T Tan,D L Gregory,S Prewett et al.
L-T Tan et al.
Aims: The EMBRACE-I study has shown that magnetic resonance imaging (MRI)-based image-guided brachytherapy (IGBT) results in local control (LC) rates of >90% across all stages without increasing late morbidity. However, r...
J K H Liu,A Nathan,J Dodkins et al.
J K H Liu et al.
Clinical Features Associated With Outcomes in Lung Cancer Patients Treated With Denosumab [0.03%]
临床特征与接受地诺单抗治疗肺癌患者预后的相关性分析
B-W Shiau,W-H Hsu,Y-F Wei et al.
B-W Shiau et al.
Aims: To investigate the association between denosumab use and 2-year all-cause mortality and incident skeletal-related events (SREs) in patients with lung cancer and bone metastases. ...